170 related articles for article (PubMed ID: 7588093)
1. [Multiple usages for antiprogestins].
Heikinheimo O
Duodecim; 1994; 110(10):1001-8. PubMed ID: 7588093
[No Abstract] [Full Text] [Related]
2. Clinical applications of the antiprogestins.
Kettel LM
Clin Obstet Gynecol; 1995 Dec; 38(4):921-34. PubMed ID: 8616987
[No Abstract] [Full Text] [Related]
3. [Anti progestins].
Fujimoto J
Nihon Rinsho; 2006 Apr; 64 Suppl 4():447-51. PubMed ID: 16689349
[No Abstract] [Full Text] [Related]
4. RU486 (mifepristone): mechanisms of action and clinical uses.
Cadepond F; Ulmann A; Baulieu EE
Annu Rev Med; 1997; 48():129-56. PubMed ID: 9046951
[TBL] [Abstract][Full Text] [Related]
5. [The molecular mechanisms of the action of antiprogestins].
Kareva EN; Solov'eva EV; Kirpichnikova NV; Tumanov AV
Eksp Klin Farmakol; 1999; 62(4):72-6. PubMed ID: 10513344
[No Abstract] [Full Text] [Related]
6. [Mifepristone--a new antiprogesterone in obstetrics and gynecology].
Aschkenazi S; Levy T; Ben-Rafael Z
Harefuah; 2001 May; 140(5):429-34. PubMed ID: 11419069
[No Abstract] [Full Text] [Related]
7. [Effect of antigestagens on human reproduction].
Zalányi S; Kovács L
Orv Hetil; 2001 Apr; 142(16):827-31. PubMed ID: 11340944
[TBL] [Abstract][Full Text] [Related]
8. Treatment for rare brain tumors veers from traditional tack.
McBride G
J Natl Cancer Inst; 1997 Jul; 89(13):912-3. PubMed ID: 9214668
[No Abstract] [Full Text] [Related]
9. Double-Blind Phase III Randomized Trial of the Antiprogestin Agent Mifepristone in the Treatment of Unresectable Meningioma: SWOG S9005.
Ji Y; Rankin C; Grunberg S; Sherrod AE; Ahmadi J; Townsend JJ; Feun LG; Fredericks RK; Russell CA; Kabbinavar FF; Stelzer KJ; Schott A; Verschraegen C
J Clin Oncol; 2015 Dec; 33(34):4093-8. PubMed ID: 26527781
[TBL] [Abstract][Full Text] [Related]
10. Hormone agonists and antagonists in the treatment of hormone sensitive breast and prostate cancer.
Nicholson RI; Walker KJ; Davies P
Cancer Surv; 1986; 5(3):463-86. PubMed ID: 3555778
[No Abstract] [Full Text] [Related]
11. [Anti-progesterones].
Sitruk-Ware R
Presse Med; 1999 Dec; 28(38):2123-31. PubMed ID: 10613204
[TBL] [Abstract][Full Text] [Related]
12. Meningioma and hormonal influences.
Wahab M; Al-Azzawi F
Climacteric; 2003 Dec; 6(4):285-92. PubMed ID: 15006250
[TBL] [Abstract][Full Text] [Related]
13. [Oncological and endocrine administration of the antiprogestagen RU 486].
Lamberts SW
Ned Tijdschr Geneeskd; 1990 Dec; 134(52):2521-4. PubMed ID: 2270126
[No Abstract] [Full Text] [Related]
14. [Mifepristone--a controversial drug with great potential].
Bjørge L; Iversen OE
Tidsskr Nor Laegeforen; 2001 Nov; 121(28):3286-91. PubMed ID: 11826459
[TBL] [Abstract][Full Text] [Related]
15. Mifepristone: antineoplastic studies.
Sartor O; Figg WD
Clin Obstet Gynecol; 1996 Jun; 39(2):498-505. PubMed ID: 8734014
[TBL] [Abstract][Full Text] [Related]
16. Clinical pharmacokinetics of mifepristone.
Heikinheimo O
Clin Pharmacokinet; 1997 Jul; 33(1):7-17. PubMed ID: 9250420
[TBL] [Abstract][Full Text] [Related]
17. Reproductive epidemiology of glial tumors may reveal novel treatments: high-dose progestins or progesterone antagonists as endocrino-immune modifiers against glioma.
Altinoz MA; Ozpinar A; Elmaci I
Neurosurg Rev; 2019 Jun; 42(2):351-369. PubMed ID: 29453736
[TBL] [Abstract][Full Text] [Related]
18. Termination of early pregnancy using flexible, low-dose mifepristone-misoprostol regimens.
Heikinheimo O; Leminen R; Suhonen S
Contraception; 2007 Dec; 76(6):456-60. PubMed ID: 18061704
[TBL] [Abstract][Full Text] [Related]
19. [Progesterone antagonists--pharmacology and perspectives of use].
Distler W; Vering A
Gynakologe; 1992 Aug; 25(4):226-30. PubMed ID: 1398251
[No Abstract] [Full Text] [Related]
20. [Progesterone antagonists: biochemical and pharmacological aspects and clinical usefulness].
Terán Dávila J; Teppa Garrán A
Ginecol Obstet Mex; 2004 Feb; 72():76-84. PubMed ID: 15216905
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
